Ocugen's (OCGN) Intranasal Vaccine Deal 'Intriguing' - Mizuho Reiterates Stock at Buy
Tweet Send to a Friend
Mizuho Securities analyst Uy Ear reiterated a Buy rating and $5.00 price target on Ocugen, Inc. (NASDAQ: OCGN), following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
